News New Zealand agency comes under pressure to pay more for drugs BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3933 (Published 21 June 2011) Cite this as: BMJ 2011;342:d3933 Article Related content Metrics Responses Peer review Related articles Analysis How New Zealand has contained expenditure on drugs Published: 18 May 2010; BMJ 340 doi:10.1136/bmj.c2441 News Drug firm’s legal action against government advisers is described as “intimidation” Published: 17 November 2010; BMJ 341 doi:10.1136/bmj.c6527 Observations Letter to an unknown health minister Published: 21 September 2011; BMJ 343 doi:10.1136/bmj.d6004 News Lilly challenges Canada’s decision to strike down patents for not meeting “inventive promise” Published: 17 September 2013; BMJ 347 doi:10.1136/bmj.f5651 See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265 Cited by... Identifying priority medicines policy issues for New Zealand: a general inductive studyAbstract Fulltext PDF Lilly challenges Canada's decision to strike down patents for not meeting "inventive promise"Abstract Fulltext PDF Will Pharmac become a victim of its own success?Abstract Fulltext PDF
